Gene: MAP6D1
Official Full Name: MAP6 domain containing 1provided by HGNC
Gene Summary: This gene encodes a protein highly similar to the mouse MAP6 domain containing 1 protein, which is related to the STOP proteins. Based on the study of the mouse protein, the encoded protein may function as a calmodulin-regulated neuronal protein that binds and stabilizes microtubules but also associates with the Golgi membranes through N-terminal palmitoylation. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16345 | MAP6D1 Knockout cell line (HCT 116) | Human | MAP6D1 | 1:2~1:4 | Negative | Online Inquiry |
KO16346 | MAP6D1 Knockout cell line (HEK293) | Human | MAP6D1 | 1:3~1:6 | Negative | Online Inquiry |
MAP6D1 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology, specifically designed to facilitate research in gene function and cellular behavior associated with the MAP6D1 gene. These cell lines have been genetically modified to silence the expression of MAP6D1, enabling researchers to explore the consequential effects of its absence on various cellular processes, including neurogenesis, cellular differentiation, and synaptic plasticity.
The key functionality of MAP6D1 Gene Knockout Cell Lines lies in their ability to elucidate the mechanisms through which MAP6D1 regulates neuronal development and function. By comparing these knockout lines with wild-type counterparts, researchers can investigate the molecular pathways affected by MAP6D1 expression, shedding light on its role in neurological disorders and synaptic dysfunctions. The knockout model enables advanced studies tailored towards understanding pathophysiological conditions, critical for the development of targeted therapeutics.
Scientifically, these cell lines are invaluable in both academic and clinical research settings. They serve as a robust platform for drug screening, functional assays, and the evaluation of therapeutic targets. Their application extends to the study of neurodegenerative diseases, making them crucial for identifying potential interventions and improving patient care outcomes.
What sets MAP6D1 Gene Knockout Cell Lines apart from other available models is their high specificity and reliability in gene manipulation, paired with thorough characterization to ensure consistent results. With rigorous validation and exceptional reproducibility, these lines provide researchers with confidence in their experimental designs.
For researchers, clinicians, and biologists, these gene knockout cell lines foster advancements in understanding critical gene functions while driving innovation in therapeutic approaches. By investing in MAP6D1 Gene Knockout Cell Lines, users are equipped with a powerful resource that promises to enhance their capabilities in translational research and drug discovery.
Our company is dedicated to offering superior biological products designed to support the forefront of scientific exploration. With a commitment to quality and innovation, we empower researchers with the tools necessary to drive groundbreaking discoveries in molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.